Skip to main content
. 2019 Nov 7;45(11):271–282. doi: 10.14745/ccdr.v45i11a01

Table 4. Sexual practices of Canadian participants in the EMIS-2017 (N=5,165).

Characteristics British Columbia + Yukon
(n=1,191)a
Alberta + Northwest Territories
(n=710)a
Saskatchewan + Manitoba
(n=339)a
Ontario + Nunavut
(n=1,707)a
Quebec
(n=789)a
Atlantic Provinces
(n=429)a
Total
(N=5,165)a
n % n % n % n % n % n % n %
Nonsober sex (last 12 months)b
None of it 362 33.1 252 41.0 125 41.7 533 35.0 253 35.8 160 44.3 1,685 36.6
Almost none of it 278 25.4 174 28.3 81 27.0 380 25.0 171 24.2 87 24.1 1,171 25.5
Less than half 141 12.9 71 11.6 26 8.7 209 13.7 92 13.0 42 11.6 581 12.6
About half 115 10.5 42 6.8 21 7.0 122 8.0 67 9.5 24 6.6 391 8.5
More than half 74 6.8 27 4.4 9 3.0 111 7.3 49 6.9 16 4.4 286 6.2
Almost all of it 97 8.9 31 5.0 31 10.3 121 8.0 58 8.2 23 6.4 361 7.8
All of it 28 2.6 17 2.8 7 2.3 46 3.0 17 2.4 9 2.5 124 2.7
Recency of chemsexc
Within six months 95 8.1 26 3.7 11 3.3 105 6.2 47 6.0 14 3.3 298 5.8
Six months to a year 76 6.5 56 7.9 14 4.1 127 7.5 50 6.4 20 4.7 343 6.7
1–5 years ago 50 4.2 37 5.2 10 3.0 62 3.7 31 3.9 12 2.8 202 3.9
5+ years ago 77 6.5 31 4.4 8 2.4 84 5.0 40 5.1 20 4.7 260 5.1
Never 879 74.7 558 78.8 295 87.3 1,311 77.6 617 78.6 357 84.4 4,017 78.5
Anal intercourse with casual partners (participants of any HIV status)d
No anal intercourse 420 36 258 36.7 125 37.3 632 37.8 308 39.6 181 42.9 1,924 37.9
Any anal intercourse 748 64 444 63.3 210 62.7 1,038 62.2 470 60.4 241 57.1 3,151 62.1
Consistent condom use with casual partners (participants of any HIV status)e
Non-consistent condom use 561 75.0 327 73.6 160 76.2 765 73.8 320 68.2 185 76.8 2,318 73.6
Consistent condom use 187 25.0 117 26.4 50 23.8 272 26.2 149 31.8 56 23.2 831 26.4
Any CAI by HIV-negative men, on PrEPf
No CAI 30 8.7
Any CAI 314 91.3
Any CAI among HIV-negative or HIV-unknown men not on PrEPg
No CAI 180 26.5 114 27.4 50 25.1 265 29.5 134 36.1 54 23.4 797 28.5
Any CAI 498 73.5 302 72.6 149 74.9 632 70.5 237 63.9 177 76.6 1,995 71.5
Any CAI by HIV-positive men, on treatment, undetectable viral loadh
No CAI 22 7.3
Any CAI 278 92.7
Any CAI among HIV-positive men not on treatment and detectable viral loadi
No CAI 12 85.7
Any CAI 2 14.3
Paid a man to have sex
Within 12 months 57 4.9 33 4.8 24 7.4 108 6.6 51 6.8 14 3.5 287 5.8
1–5 years 61 5.3 27 4.0 15 4.6 89 5.4 34 4.5 16 4.0 242 4.9
5+ years 78 6.7 31 4.6 19 5.9 113 6.9 38 5.1 18 4.4 297 6.0
Never 961 83.1 590 86.6 266 82.1 1,333 81.1 626 83.6 357 88.1 4,133 83.3
Paid by a man to have sex
Within 12 months 40 3.5 30 4.4 7 2.2 67 4.1 36 4.8 20 4.9 200 4.0
1–5 years ago 44 3.8 22 3.2 12 3.7 72 4.4 44 5.9 17 4.2 211 4.3
5+ years ago 114 9.9 43 6.3 24 7.4 153 9.3 33 4.4 25 6.2 392 7.9
Never 959 82.9 586 86.0 281 86.7 1,353 82.2 637 84.9 344 84.7 4,160 83.8

Abbreviations: CAI,condomless anal intercourse; PrEP, preexposure prophylaxis; –, numbers were suppressed due to small cell sizes

a The total counts for each characteristic do not always add up to the provincial totals because only participants with non-missing values were included. Missing values make up less than 5% of the totals

b Among men who have had sex with a man in last 12 months (N=4,599)

c Used stimulant drugs to make sex more intense or last longer. Note: The stimulant drugs include ecstasy/MDMA, cocaine, amphetamine (speed), crystal methamphetamine (Tina, Pervitin), mephedrone and ketamine

d Among men of any HIV status who had one or more casual partners in the last 12 months (N=5,075)

e Among men of any HIV status who had anal intercourse with one or more casual partners in the last 12 months (N=3,149)

f Among HIV-negative men on PrEP who had anal intercourse with one or more casual partners in last 12 months (N=344)

g Among HIV-negative or untested men not on PrEP who had anal intercourse with one or more casual partners in last 12 months (N=2,792)

h Among HIV-positive men on treatment and undetectable viral load who had anal intercourse with one or more casual partners in last 12 months (N=300)

i Among HIV-positive men not on treatment and with a detectable viral load who had anal intercourse with one or more casual partners in last 12 months (N=21)